ヒト化マウスモデルの世界市場2023年~2027年

◆英語タイトル:Global Humanized Mouse Model Market 2023-2027

Technavioが発行した調査報告書(IRTNTR43762-23)◆商品コード:IRTNTR43762-23
◆発行会社(リサーチ会社):Technavio
◆発行日:2023年3月14日
◆ページ数:約120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア、その他地域
◆産業分野:生命科学
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

テクナビオ社では、世界のヒト化マウスモデル市場規模が2022年から2027年の間に133.23百万ドルに拡大すると予測しており、予測期間中に年平均13.18%成長する見通しです。本調査資料ではヒト化マウスモデルの世界市場について調査・分析を行い、エグゼクティブサマリー、市場状況、市場規模予測、過去の市場規模、ファイブフォース分析、製品別(遺伝性ヒト化マウスモデル、細胞ベースヒト化マウスモデル)分析、エンドユーザー別(製薬&バイオ企業、CRO、学術&研究機関)分析、地域別(北米、ヨーロッパ、アジア、その他地域、アメリカ、フランス、中国、イギリス、日本)分析、顧客状況、推進要因・課題・動向、企業状況、企業分析など、以下のように掲載しています。また、企業情報として、Altogen labs, Biocytogen, BioSafety Research Center Inc., Champions Oncology Inc., Charles River Laboratories International Inc., Creative Biolabs, Cyagen Biosciences, Envigo, Gempharmatech Co. Ltd., genOway, Harbour Biomed, Hera Biolabs Inc., Horizon Discovery Ltd., ingenious targeting laboratory, JANVIER LABS, Ozgene Pty Ltd., PolyGene AG, Taconic Biosciences Inc., The Jackson Laboratory, Yecuris Corp.などが含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模予測
・過去の市場規模
・ファイブフォース分析
・世界のヒト化マウスモデル市場規模:製品別
- 遺伝性ヒト化マウスモデルの市場規模
- 細胞ベースヒト化マウスモデルの市場規模
・世界のヒト化マウスモデル市場規模:エンドユーザー別
- 製薬&バイオ企業における市場規模
- CROにおける市場規模
- 学術&研究機関における市場規模
・顧客状況
・世界のヒト化マウスモデル市場規模:地域別
- 北米のヒト化マウスモデル市場規模
- ヨーロッパのヒト化マウスモデル市場規模
- アジアのヒト化マウスモデル市場規模
- その他地域のヒト化マウスモデル市場規模
- アメリカのヒト化マウスモデル市場規模
- フランスのヒト化マウスモデル市場規模
- 中国のヒト化マウスモデル市場規模
- イギリスのヒト化マウスモデル市場規模
- 日本のヒト化マウスモデル市場規模
・推進要因・課題・動向
・企業状況
・企業分析

テクナビオ社は、利益・価格・競争・プロモーションなどの主なパラメーターを分析することにより、複数の情報源からのデータを調査・統合・統括することで、ヒト化マウスモデル市場の詳細な全体像を提示します。主要産業のインフルエンサーを特定することにより、多様な市場の側面を提示します。これらのデータは包括的​​且つ信頼性が高く、一次・二次の広範な調査の結果です。テクナビオ社の市場調査資料は、正確なヒト化マウスモデル市場の成長を予測するため、定性的・定量的調査により徹底的な競合状況、詳細に及ぶベンダー選定&分析を提供します。

ヒト化マウスモデルの世界市場 2023-2027

Technavio社は、ヒト化マウスモデル市場をモニターしており、2022年から2027年にかけて133.23百万ドルの成長が予測され、予測期間中のCAGRは13.18%で加速すると予測しています。当レポートでは、ヒト化マウスモデル市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析も掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、個別化医療の採用拡大、革新的なアプリケーション、遺伝子工学技術の進歩によって牽引されています。

Technavio社のヒト化マウスモデル市場は以下のように分類されます:

・製品別:
- 遺伝子組み換えヒト化マウスモデル
- 細胞系ヒト化マウスモデル

・エンドユーザー別:
- 製薬・バイオテクノロジー企業
- CRO
- 学術・研究機関

・地域別:
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

本調査では、戦略的提携が今後数年間のヒト化マウスモデル市場の成長を促進する主要な理由の1つであると特定しています。また、MABの生産量の増加と全動物イメージングの出現は、市場の大きな需要につながるでしょう。

Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。当レポートでは、ヒト化マウスモデル市場について以下の分野をカバーしています:
- ヒト化マウスモデル市場のサイジング
- ヒト化マウスモデル市場予測
- ヒト化マウスモデル市場の産業分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、Altogen labs, Biocytogen, BioSafety Research Center Inc., Champions Oncology Inc., Charles River Laboratories International Inc., Creative Biolabs, Cyagen Biosciences, Envigo, Gempharmatech Co. Ltd., genOway, Harbour Biomed, Hera Biolabs Inc., Horizon Discovery Ltd., ingenious targeting laboratory, JANVIER LABS, Ozgene Pty Ltd., PolyGene AG, Taconic Biosciences Inc., The Jackson Laboratory, and Yecuris Corpなどの企業情報が含まれています。また、ヒト化マウスモデル市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global humanized mouse model market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global humanized mouse model market 2017 – 2021 ($ million)
o 4.2 Product Type Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Product Type Segment 2017 – 2021 ($ million)
o 4.3 End-user Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – End-user Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product – Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Genetically humanized mouse model – Market size and forecast 2022-2027
o Exhibit 34: Chart on Genetically humanized mouse model – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Genetically humanized mouse model – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Genetically humanized mouse model – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Genetically humanized mouse model – Year-over-year growth 2022-2027 (%)
o 6.4 Cell-based humanized mouse model – Market size and forecast 2022-2027
o Exhibit 38: Chart on Cell-based humanized mouse model – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Cell-based humanized mouse model – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Cell-based humanized mouse model – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Cell-based humanized mouse model – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ million)
o Exhibit 43: Data Table on Market opportunity by Product ($ million)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 44: Chart on End-user – Market share 2022-2027 (%)
o Exhibit 45: Data Table on End-user – Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 46: Chart on Comparison by End-user
o Exhibit 47: Data Table on Comparison by End-user
o 7.3 Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027
o Exhibit 48: Chart on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)
o 7.4 CROs – Market size and forecast 2022-2027
o Exhibit 52: Chart on CROs – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on CROs – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on CROs – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on CROs – Year-over-year growth 2022-2027 (%)
o 7.5 Academic and research institutions – Market size and forecast 2022-2027
o Exhibit 56: Chart on Academic and research institutions – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Academic and research institutions – Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Academic and research institutions – Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Academic and research institutions – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by End-user
o Exhibit 60: Market opportunity by End-user ($ million)
o Exhibit 61: Data Table on Market opportunity by End-user ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share by geography 2022-2027 (%)
o Exhibit 64: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 67: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 75: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 83: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 UK – Market size and forecast 2022-2027
o Exhibit 87: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.9 France – Market size and forecast 2022-2027
o Exhibit 91: Chart on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on France – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on France – Year-over-year growth 2022-2027 (%)
o 9.10 China – Market size and forecast 2022-2027
o Exhibit 95: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 99: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 103: Market opportunity by geography ($ million)
o Exhibit 104: Data Tables on Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Biocytogen
o Exhibit 111: Biocytogen – Overview
o Exhibit 112: Biocytogen – Product / Service
o Exhibit 113: Biocytogen – Key offerings
o 12.4 BioSafety Research Center Inc.
o Exhibit 114: BioSafety Research Center Inc. – Overview
o Exhibit 115: BioSafety Research Center Inc. – Product / Service
o Exhibit 116: BioSafety Research Center Inc. – Key offerings
o 12.5 Champions Oncology Inc.
o Exhibit 117: Champions Oncology Inc. – Overview
o Exhibit 118: Champions Oncology Inc. – Product / Service
o Exhibit 119: Champions Oncology Inc. – Key news
o Exhibit 120: Champions Oncology Inc. – Key offerings
o 12.6 Charles River Laboratories International Inc.
o Exhibit 121: Charles River Laboratories International Inc. – Overview
o Exhibit 122: Charles River Laboratories International Inc. – Business segments
o Exhibit 123: Charles River Laboratories International Inc. – Key news
o Exhibit 124: Charles River Laboratories International Inc. – Key offerings
o Exhibit 125: Charles River Laboratories International Inc. – Segment focus
o 12.7 Creative Biolabs
o Exhibit 126: Creative Biolabs – Overview
o Exhibit 127: Creative Biolabs – Product / Service
o Exhibit 128: Creative Biolabs – Key offerings
o 12.8 Cyagen Biosciences
o Exhibit 129: Cyagen Biosciences – Overview
o Exhibit 130: Cyagen Biosciences – Product / Service
o Exhibit 131: Cyagen Biosciences – Key offerings
o 12.9 Envigo
o Exhibit 132: Envigo – Overview
o Exhibit 133: Envigo – Product / Service
o Exhibit 134: Envigo – Key offerings
o 12.10 Gempharmatech Co. Ltd.
o Exhibit 135: Gempharmatech Co. Ltd. – Overview
o Exhibit 136: Gempharmatech Co. Ltd. – Product / Service
o Exhibit 137: Gempharmatech Co. Ltd. – Key offerings
o 12.11 genOway
o Exhibit 138: genOway – Overview
o Exhibit 139: genOway – Product / Service
o Exhibit 140: genOway – Key offerings
o 12.12 Harbour Biomed
o Exhibit 141: Harbour Biomed – Overview
o Exhibit 142: Harbour Biomed – Product / Service
o Exhibit 143: Harbour Biomed – Key offerings
o 12.13 Hera Biolabs Inc.
o Exhibit 144: Hera Biolabs Inc. – Overview
o Exhibit 145: Hera Biolabs Inc. – Product / Service
o Exhibit 146: Hera Biolabs Inc. – Key offerings
o 12.14 ingenious targeting laboratory
o Exhibit 147: ingenious targeting laboratory – Overview
o Exhibit 148: ingenious targeting laboratory – Product / Service
o Exhibit 149: ingenious targeting laboratory – Key offerings
o 12.15 JANVIER LABS
o Exhibit 150: JANVIER LABS – Overview
o Exhibit 151: JANVIER LABS – Product / Service
o Exhibit 152: JANVIER LABS – Key offerings
o 12.16 Taconic Biosciences Inc.
o Exhibit 153: Taconic Biosciences Inc. – Overview
o Exhibit 154: Taconic Biosciences Inc. – Product / Service
o Exhibit 155: Taconic Biosciences Inc. – Key offerings
o 12.17 The Jackson Laboratory
o Exhibit 156: The Jackson Laboratory – Overview
o Exhibit 157: The Jackson Laboratory – Product / Service
o Exhibit 158: The Jackson Laboratory – Key news
o Exhibit 159: The Jackson Laboratory – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 160: Inclusions checklist
o Exhibit 161: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 162: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 163: Research methodology
o Exhibit 164: Validation techniques employed for market sizing
o Exhibit 165: Information sources
o 13.5 List of abbreviations
o Exhibit 166: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Product
Exhibits6: Executive Summary – Chart on Market Segmentation by End-user
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global humanized mouse model market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Product Type Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – End-user Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Product – Market share 2022-2027 (%)
Exhibits31: Data Table on Product – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Genetically humanized mouse model – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Genetically humanized mouse model – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Genetically humanized mouse model – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Genetically humanized mouse model – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Cell-based humanized mouse model – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Cell-based humanized mouse model – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Cell-based humanized mouse model – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Cell-based humanized mouse model – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Data Table on Market opportunity by Product ($ million)
Exhibits44: Chart on End-user – Market share 2022-2027 (%)
Exhibits45: Data Table on End-user – Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by End-user
Exhibits47: Data Table on Comparison by End-user
Exhibits48: Chart on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on CROs – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on CROs – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on CROs – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on CROs – Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Academic and research institutions – Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Academic and research institutions – Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Academic and research institutions – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Academic and research institutions – Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by End-user ($ million)
Exhibits61: Data Table on Market opportunity by End-user ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share by geography 2022-2027 (%)
Exhibits64: Data Table on Market share by geography 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on France – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on France – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on France – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on France – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity by geography ($ million)
Exhibits104: Data Tables on Market opportunity by geography ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Biocytogen – Overview
Exhibits112: Biocytogen – Product / Service
Exhibits113: Biocytogen – Key offerings
Exhibits114: BioSafety Research Center Inc. – Overview
Exhibits115: BioSafety Research Center Inc. – Product / Service
Exhibits116: BioSafety Research Center Inc. – Key offerings
Exhibits117: Champions Oncology Inc. – Overview
Exhibits118: Champions Oncology Inc. – Product / Service
Exhibits119: Champions Oncology Inc. – Key news
Exhibits120: Champions Oncology Inc. – Key offerings
Exhibits121: Charles River Laboratories International Inc. – Overview
Exhibits122: Charles River Laboratories International Inc. – Business segments
Exhibits123: Charles River Laboratories International Inc. – Key news
Exhibits124: Charles River Laboratories International Inc. – Key offerings
Exhibits125: Charles River Laboratories International Inc. – Segment focus
Exhibits126: Creative Biolabs – Overview
Exhibits127: Creative Biolabs – Product / Service
Exhibits128: Creative Biolabs – Key offerings
Exhibits129: Cyagen Biosciences – Overview
Exhibits130: Cyagen Biosciences – Product / Service
Exhibits131: Cyagen Biosciences – Key offerings
Exhibits132: Envigo – Overview
Exhibits133: Envigo – Product / Service
Exhibits134: Envigo – Key offerings
Exhibits135: Gempharmatech Co. Ltd. – Overview
Exhibits136: Gempharmatech Co. Ltd. – Product / Service
Exhibits137: Gempharmatech Co. Ltd. – Key offerings
Exhibits138: genOway – Overview
Exhibits139: genOway – Product / Service
Exhibits140: genOway – Key offerings
Exhibits141: Harbour Biomed – Overview
Exhibits142: Harbour Biomed – Product / Service
Exhibits143: Harbour Biomed – Key offerings
Exhibits144: Hera Biolabs Inc. – Overview
Exhibits145: Hera Biolabs Inc. – Product / Service
Exhibits146: Hera Biolabs Inc. – Key offerings
Exhibits147: ingenious targeting laboratory – Overview
Exhibits148: ingenious targeting laboratory – Product / Service
Exhibits149: ingenious targeting laboratory – Key offerings
Exhibits150: JANVIER LABS – Overview
Exhibits151: JANVIER LABS – Product / Service
Exhibits152: JANVIER LABS – Key offerings
Exhibits153: Taconic Biosciences Inc. – Overview
Exhibits154: Taconic Biosciences Inc. – Product / Service
Exhibits155: Taconic Biosciences Inc. – Key offerings
Exhibits156: The Jackson Laboratory – Overview
Exhibits157: The Jackson Laboratory – Product / Service
Exhibits158: The Jackson Laboratory – Key news
Exhibits159: The Jackson Laboratory – Key offerings
Exhibits160: Inclusions checklist
Exhibits161: Exclusions checklist
Exhibits162: Currency conversion rates for US$
Exhibits163: Research methodology
Exhibits164: Validation techniques employed for market sizing
Exhibits165: Information sources
Exhibits166: List of abbreviations



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ヒト化マウスモデルの世界市場2023年~2027年(Global Humanized Mouse Model Market 2023-2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆